Abstract
| Lingua originale | English |
|---|---|
| Pagine | 71-72 |
| Numero di pagine | 2 |
| Stato di pubblicazione | Published - 2017 |
Fingerprint
Cita questo
Anti-cancer effects of Pleurotus eryngii var. eryngii: an in vitro and in vivo models focusing on Heat Shock Proteins. / Gargano, Maria Letizia; Marino Gammazza, Antonella; Venturella, Giuseppe; D'Amico, Daniela; Campanella, Claudia; Di Felice, Valentina; Trovato, Eleonora; Barone, Rosario; Rappa, Francesca; Caruso Bavisotto, Celeste; Cappello, Francesco.
2017. 71-72.Risultato della ricerca: Other
}
TY - CONF
T1 - Anti-cancer effects of Pleurotus eryngii var. eryngii: an in vitro and in vivo models focusing on Heat Shock Proteins
AU - Gargano, Maria Letizia
AU - Marino Gammazza, Antonella
AU - Venturella, Giuseppe
AU - D'Amico, Daniela
AU - Campanella, Claudia
AU - Di Felice, Valentina
AU - Trovato, Eleonora
AU - Barone, Rosario
AU - Rappa, Francesca
AU - Caruso Bavisotto, Celeste
AU - Cappello, Francesco
PY - 2017
Y1 - 2017
N2 - Heat shock proteins (Hsps) are highly expressed in a variety of cancer cells and are essential to their survival contributing to tumor cell propagation, metastasis, and protection against apoptosis]. Cancer is a leading cause of death worldwide.The current anti-cancer drugs available in market are not target specific and pose several side-effects and complications in clinical management of various forms of cancer, which highlights the urgent need for novel effective and less-toxictherapeutic approaches. Medicinal mushrooms have emerged as wonderful source of nutraceuticals, anti-oxidants, anticancer, prebiotic, anti-inflammatory, cardiovascular, anti-microbial, and anti-diabetic. The ongoing research projects areaimed to promote mushrooms as new generation ‘‘biotherapeutics". The aim of this study was to evaluate whether the cold-water extracts of Pleurotus eryngii var. eryngii can affect Hsp90, 70, 60 and 27 levels in an in vitro model of colon cancer (C26 cells). Cell viability was evaluated using MTT assay after treating the cells with different concentrations of extracts (0-1.9 μg/μl) in the culture medium for 24 and 48 hours. Hsp90, 70, 60 and 27 levels were measured using western blotting and immunofluorescence analysis. Moreover, we evaluated the anticancer effect of the P. eryngii var. eryngii extract in an animal model of ectopically-implanted C26 colon carcinoma, widely used as an experimental model of cancer cachexia. We prepared a mixture of lyophilized P. eryngii var. eryngii with the mice standard diet and the animals were daily fed with ~4g of the mix until they died to draw a survival curve. Our results showed that the extract significantly decreased cells viability at 0.48 μg/μl after both 24 and 48 hours of treatments. Western blotting analysis and immunofluorescence showed that Hsp60 protein levels were down-regulate at 24h of treatment but increased after 48h. On the contrary, Hsp90, 70 and 27 protein levels did not changed. In the in vivo model, P. eryngii var. eryngii in the diet significantly extended the median survival compared to untreated mice. These preliminary results are promising for further studies to better understand the potential anticancer effect of P. eryngii var. eryngii.
AB - Heat shock proteins (Hsps) are highly expressed in a variety of cancer cells and are essential to their survival contributing to tumor cell propagation, metastasis, and protection against apoptosis]. Cancer is a leading cause of death worldwide.The current anti-cancer drugs available in market are not target specific and pose several side-effects and complications in clinical management of various forms of cancer, which highlights the urgent need for novel effective and less-toxictherapeutic approaches. Medicinal mushrooms have emerged as wonderful source of nutraceuticals, anti-oxidants, anticancer, prebiotic, anti-inflammatory, cardiovascular, anti-microbial, and anti-diabetic. The ongoing research projects areaimed to promote mushrooms as new generation ‘‘biotherapeutics". The aim of this study was to evaluate whether the cold-water extracts of Pleurotus eryngii var. eryngii can affect Hsp90, 70, 60 and 27 levels in an in vitro model of colon cancer (C26 cells). Cell viability was evaluated using MTT assay after treating the cells with different concentrations of extracts (0-1.9 μg/μl) in the culture medium for 24 and 48 hours. Hsp90, 70, 60 and 27 levels were measured using western blotting and immunofluorescence analysis. Moreover, we evaluated the anticancer effect of the P. eryngii var. eryngii extract in an animal model of ectopically-implanted C26 colon carcinoma, widely used as an experimental model of cancer cachexia. We prepared a mixture of lyophilized P. eryngii var. eryngii with the mice standard diet and the animals were daily fed with ~4g of the mix until they died to draw a survival curve. Our results showed that the extract significantly decreased cells viability at 0.48 μg/μl after both 24 and 48 hours of treatments. Western blotting analysis and immunofluorescence showed that Hsp60 protein levels were down-regulate at 24h of treatment but increased after 48h. On the contrary, Hsp90, 70 and 27 protein levels did not changed. In the in vivo model, P. eryngii var. eryngii in the diet significantly extended the median survival compared to untreated mice. These preliminary results are promising for further studies to better understand the potential anticancer effect of P. eryngii var. eryngii.
UR - http://hdl.handle.net/10447/279021
M3 - Other
SP - 71
EP - 72
ER -